This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Investor Alert: Federman & Sherwood Reminds Investors With Losses In Invacare Corporation Of Upcoming Deadline In Securities Class Action Lawsuit

Federman & Sherwood announces that on May 24, 2013, a class action lawsuit was filed in the United States District Court for the Northern District of Ohio against Invacare Corporation (NYSE: IVC) for possible federal securities laws violations surrounding the Company’s failure to disclose adverse facts about IVC during the Class Period (7/22/2010 through 12/7/2011). More specifically, the Complaint alleges the Company was issuing a series of false or misleading statements, or was failing to disclose, IVC’s non-compliance with FDA guidelines and Current Good Manufacturing Practices (“CGMP”). The Complaint also alleges the Company was suffering from widespread operational, quality and regulatory deficiencies, and had received a series of warning letters from the FDA identifying serious compliance violations at its two major U.S. manufacturing facilities. Allegedly, all of these facts were concealed from investors. On January 4, 2011, the FDA released a warning letter to the public identifying the CGMP violations and “recurring” consumer complaints concerning the safety of the Company’s medical beds. That day IVC’s stock declined $1.38 per share, to close at $29.29 per share on that date. However, the Complaint alleges IVC continued to downplay the significance of the Company’s compliance issues, despite receiving 2 more FDA warning letters, which were also concealed from investors. On December 8, 2011, the Company issued a press release announcing that the FDA intended to suspend certain IVC operations until the Company’s manufacturing facilities became FDA compliant. Upon this news, the Company’s stock prices declined $5.88 per share. The Complaint therefore alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act, and Rule 10b-5 promulgated thereunder.

If you purchased Invacare Corporation shares between July 22, 2010 and December 7, 2011, have large losses as a result of your trades during this time period, and wish to join this litigation as a potential lead plaintiff, please contact our office as soon as possible. Investors only have until Tuesday, July 23, 2013 to move the court for consideration as a court-appointed lead plaintiff in this action. Our firm seeks to recover damages and losses on behalf of the entire Class. Federman & Sherwood has extensive nationwide experience and expertise in prosecuting securities litigation involving financial fraud. If you wish to join this class action or have further questions, please contact at www.federmanlaw.com.



Stock quotes in this article: IVC 
Copyright Business Wire 2010

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.9670 -34.4910 -0.83%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs